As theranostics reshapes cancer care, the ability to image every therapeutic isotope on a single platform has become nuclear medicine's next frontier. Spectrum Dynamics Medical, the global leader in digital SPECT/CT imaging, announced the launch of the VERITON-CT 400 Series with a new All-Energy Enhancement. The first customer experience for this improved technology is now complete at Florida Theranostics in Jupiter, Florida. That early work spanned low-, medium-, and high-energy clinically available isotopes, including those central to modern theranostics (e.g., Tc-99m, I-123, Lu-177, I-131), on patients in a clinical setting.
The enhancement improves precision, sensitivity, and resolution while maintaining the system's fast scan times. It preserves the single-collimator design's simplicity while extending the platform's end-to-end detection and processing capabilities, supporting the growing role of theranostics, quantitative imaging, and novel radiopharmaceuticals in nuclear medicine. The enhancement is available on new VERITON-CT 400 systems and as an upgrade for existing installations.
"This launch marks an important milestone and a historic day in our mission to provide nuclear medicine professionals around the world with a single digital platform capable of supporting all energies of imaging across modern theranostics, nuclear cardiology, and general nuclear medicine, with one goal in mind: imaging without compromise," said Tomer Gabay, Chief Executive Officer of Spectrum Dynamics Medical. "The early experience at Florida Theranostics demonstrates what is possible when sustained technological innovation is combined with close clinical collaboration. We are proud to begin bringing this capability to customers through a truly all-energy digital SPECT/CT platform that enables imaging across all clinically available isotopes without compromising image quality, clinical performance, or workflow, and without the need to change collimators. This is the future of SPECT imaging: one platform, every isotope, no compromises."
According to Yulim Zingerman, Ph.D., Chief Technology Officer of Spectrum Dynamics Medical, achieving imaging across this range of photon energies required a system-level approach integrating digital CZT detection, 360-degree geometry, reconstruction, quantification, and clinical workflow.
